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Mice Transgenic for KitV620A: Recapitulation of
Piebaldism but not Progressive Depigmentation
Seen in Humans with this Mutation
Hiroko Tosaki1, Takahiro Kunisada2, Tsutomu Motohashi2, Hitomi Aoki2, Hisahiro Yoshida3 and
Yasuo Kitajima1
Piebaldism is an autosomal dominant genetic pigmentary disorder, characterized by congenital white hair and
patches located on the forehead, anterior trunk, and extremities. Most piebald patients have a mutation of the
KIT gene, which encodes a tyrosine kinase receptor involved in pigment cell development. The white hair and
patches of such patients are already completely formed at birth and do not usually expand thereafter. This
stability of pigmented spots also applies to KitW and KitlSl mutant mice. However, two novel cases of piebaldism
were reported in 2001, in which both mother and daughter having a novel Val620Ala mutation in their KIT gene
showed progressive depigmentation. To prepare an animal model of this mutation, to explore undefined
functions of KIT signaling for maintaining pigmented melanocytes in the skin or more specifically the integrity
of the melanocyte stem cell system in the postnatal skin, we produced transgenic mice expressing Val620Ala Kit.
These mice well mimicked the white spotting pattern of patients; however, no change in this pattern was
observed after birth, even after increasing the transgene expression by various means. Here, we report the
unexpectedly extremely stable maintenance of the melanocyte stem cell system under stringent conditions for
KIT signaling.
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INTRODUCTION
Piebaldism is a relatively rare autosomal dominant genetic
pigmentary disorder, characterized by congenital white hair
and patches located on the forehead, anterior trunk, and
extremities (Keeler, 1934; Froggat, 1951; Cooke, 1952;
Fleischman, 1993; Baxter et al., 2004). In the region of these
white patches, melanocytes are almost totally lacking, and
therefore piebaldism is thought to be because of defective
proliferation, differentiation, or migration of melanocyte
precursor or stem cells from the neural crest during
development. Melanocytes develop from neural crest cells,
and in mice their progenitors migrate from the neural crest to
the dermis lateroventrally to cover the whole skin. Melano-
cytes that migrate into developing bulbs of hair follicles
become established there to give rise to melanized hair. The
generation of these cells from neural crest stem cells depends
on a complex interplay between cell-extrinsic and cell-
intrinsic factors (Dorsky et al., 2000; Dupin and Le Douarin,
2003; Hirobe, 2005). Genetic evidence indicates that
pigment cell development requires steel factor (SLF, also
called KIT-ligand, stem cell factor, or mast cell growth factor),
which acts through the tyrosine kinase receptor KIT. The
proto-oncogene Kit/KIT is a gene encoding a tyrosine kinase
receptor and has been mapped to the dominant white
spotting locus, and the ligand SLF has been mapped to the
Steel locus (Geissler et al., 1988; Copeland et al., 1990;
Kunisada et al., 2001; Yoshida et al., 2001; Wehrle-Haller,
2003). Pigment cell development further depends on
endothelin 3, which acts through the G-protein-coupled
endothelin receptor B (Baynash et al., 1994; Pla and Larue,
2003) and also on transcription factors that include the SRY-
like high mobility group protein SOX10 and the basic helix-
loop-helix leucine zipper protein microphthalmia transcrip-
tion factor (Hodgkinson et al., 1993; Tachibana et al., 1994;
Southard-Smith et al., 1998). Most patients with piebaldism
have a mutation of their KIT gene; and many mutant KIT
genes including those because of a missense mutation,
nonsense mutation, frame-shift mutation, splice-site muta-
tion, in-frame mutation, and various complete and partial
large deletions have been reported to exist in individuals with
piebaldism (Fleischman et al., 1991; Giebel and Spritz, 1991;
Spritz et al., 1992; Fleischman, 1992; Murakami et al., 2004).
Although there seems to be a difference in clinical severity
with respect to the location or pattern of the KIT gene muta-
See related commentary on page 949
& 2006 The Society for Investigative Dermatology www.jidonline.org 1111
ORIGINAL ARTICLE
Received 27 June 2005; revised 18 November 2005; accepted 8 December
2005; published online 2 February 2006
1Department of Dermatology, Gifu University School of Medicine, Gifu,
Japan; 2Department of Tissue and Organ Development, Regeneration and
Advanced Medical Science, Gifu University Graduate School of Medicine,
Gifu, Japan and 3Laboratory for Immunogenetics, RIKEN Research Center for
Allergy and Immunology, Yokohama, Japan
Correspondence: Professor Takahiro Kunisada, Department of Dermatology,
Gifu University School of Medicine, Gifu 501-1194, Japan. E-mail:
tkunisad@cc.gifu-u.ac.jp
Abbreviations: ACK2, anti-c-kit monoclonal antibody; MT-I, metallothionein-I;
SLF, steel factor; Tg, transgenic
tion, the stability of unpigmented skin regions throughout life
is known as one of the common characteristics among
patients with piebaldism. In these patients, usually the white
hair and patches have already completely formed at birth or
within several months after birth. Throughout life thereafter,
neither expansion of already formed patches nor the
appearance of new ones has been seen. This is also the case
in KitW or KitlSl mutant mice, in some of which once acquired
unpigmented spots (in some cases better to be referred as
white spots) are stably maintained throughout life, as far as
we observed for KitW57/W57, KitW/þ , KitWv/þ , KitlSl/þmice
during the maintenance of these lines. In addition, unpig-
mented spots of other mutant mice such as Mitfmi/þ and
Sox10DOM/þ do not change. In these mutant mice, genetic
lesions are severe enough to prevent cells of the melanocyte
lineage from developing properly to cover most of the skin;
however, these lesions do not affect the postnatal develop-
ment of melanocytes in the hair follicles. Clearly, the
threshold of signals required for melanocyte development is
different in embryonic and postnatal development.
Considering these facts, the novel case, reported in 2001,
that a mother and daughter with piebaldism showed
progressive depigmentation was quite exceptional (Richards
et al., 2001). This paper noted that these patients with
piebaldism were born with a white forelock and that their first
patch of depigmentation developed within half a year after
birth. But surprisingly, their depigmentation gradually pro-
gressed during childhood. It should be emphasized that the
depigmentation could be distinguished from vitiligo by its
congenital nature with whitening of hair as well as skin;
however, the pigmented border region around the white spots
receded over time. Then a novel Val620Ala (1859T4C)
mutation in the cytoplasmic kinase insert region of the KIT
gene was found in these patients. The mechanism underlying
the effect of this exceptional KIT mutation may reveal some
previously unknown function of KIT signaling to maintain
pigmented melanocytes in the skin or more specifically the
integrity of the melanocyte stem cell system in the postnatal
skin, including self-renewal of melanocyte stem cells during
the hair cycle. Aiming to reproduce this phenomenon in an
animal model, we produced transgenic (Tg) mice expressing
cDNA with the same Val620Ala mutation in the Kit gene.
RESULTS
Rationale for constructing mouse version of KITV620A mutant
To create a phenotype as close to that of the human
piebaldism because of the KITV620A mutation in a mouse
model, we used the mouse Kit cDNA sequence rather than
the human KIT cDNA for the following reasons: Firstly,
overall ligand specificity of KIT molecules might be different
between mouse and human, because the amino-acid
sequence diversity of the ligand-binding extracellular region
of KIT is prominent in these species (Marklund et al., 1999).
In fact, although mouse Slf stimulates human KIT as
effectively as it does mouse Kit, human SLF is known to act
less effectively when stimulating mouse Kit (Zsebo et al.,
1990; Lev et al., 1992; Majumdar et al., 1996). Secondly, the
region containing the KITV620A mutation site is extremely well
preserved in human and mouse; that is, among the 114
amino-acid residues from 549 to 662 of the cytoplasmic
tyrosine kinase domain of the two species containing the
Val620Ala mutation, only one isoleucine to valine alteration
was found. Therefore, if the KITV620A mutation itself
represents an intrinsic trait for the specific phenotype of
progressive human piebaldism, the same amino-acid change
in the extremely well-conserved sequence in the mouse Kit
cDNA would be likely to express the same phenotype in the
mouse model. Actually a previous report showed that the
phenotype produced by the same Kit/KIT mutation in two
different species, human and mouse, was very similar
(Fleischman, 1992). As the dominant-negative effects of
mutant KIT molecules was previously well established (Ray
et al., 1991; Spritz et al., 1992), we sought to express a
significant amount of KitV620A cDNA in mouse melanocytes
by using the metallothionein-I (MT-I) promoter sequence
(Palmiter et al., 1993).
Establishment of mt-KitV620A Tg mice recapitulating human
piebaldism and expression of transgene mRNAs in their skin
Seven independent Tg mice expressing the mutant Kit (mt-Kit)
transgene driven by the MT-I promoter were identified by
PCR. Four of them stably transmitted their white hair color
phenotypes and were named mt-KitV620A Tg-1 to 4. Two
lines, mt- KitV620A Tg-1 and mt-KitV620A Tg-2, showed a
similar coat color pattern during postnatal development;
namely, they displayed white-spotted areas on their forehead,
the back along the posterior median line, and the ventral side
(Figure 1a). The shape of the white spot in each area was very
close, that is, a diamond-shaped white spot on the forehead,
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Figure 1. Coat color phenotypes of 4-month-old mt-KitV620A Tg mice and the
stability of the coat color pattern. (a) Founders of Tg mouse lines mt-KitV620A
Tg-1 to -4 are shown. The mt-KitV620A Tg-1 F0 and Tg-2 F0 had a few white
spots on their forehead and back, and a wide range of white region on their
ventral side, whereas the mt-KitV620A Tg-3 F0 had only a narrow white spot
around its external genitalia. The fourth founder, mt-KitV620A Tg-4 F0, had a
wide region of white hair, with the remaining normal black hair extending
asymmetrically and zonally from the dorsal midline toward the ventral side.
(b) These photographed mice, mt-KitV620A Tg-1 and Tg-4, were partially
shaved; and their coat color pattern recovered precisely to their respective
original ones shown in (a) after 3 weeks.
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larger diamond-shaped and small-size white spots on the
back, and a large white spot covering most of the ventral side.
This coat color pattern well corresponds to the typical
pigmentation pattern of W mutant mice (Silvers, 1979; Nocka
et al., 1990; Besmer et al., 1993) and patients with
piebaldism (Keeler, 1934; Froggat, 1951; Cooke, 1952), thus
suggesting that the pattern is likely a consequence of
impaired Kit signaling by the transgene. All progenies
produced by mating these mice with C57BL/6 displayed a
similar white spot pattern even after the fourth generation,
indicating that this pattern is a genetically transmitted
characteristic as in W mutant mice. Another line, mt-KitV620A
Tg-3, showed only a narrow white spot around the external
genitalia (Figure 1a). The Tg mouse that expressed the most
abnormal phenotype for coat color was line 4, mt- KitV620A
Tg-4. The white-spotted area of this mouse reached 70% or
more of the body surface. Areas of pigmented hair appeared
on the right side of the body as did black stripes that extended
from the dorsal midline toward the ventral side, as shown in
Figure 1a. Progenies produced by mating Tg-4 with C57BL/6
showed similar patterns varying in different width, length,
and number of the pigmented areas: but all maintained the
common phenotype of asymmetrical and narrow lines of
pigmented hairs extending from the back to the abdomen.
Even after four or more generations, these line 4 mice had a
diamond-shaped white spot on their forehead, and the
specific coat pattern of the founder. Thus, we also regarded
the line 4 phenotype as a stably transmitted genetical trait. All
mice of mt-KitV620A Tg-1–4 had black eyes, and none showed
any symptoms of anemia or infertility (data not shown).
Expression of the transgene mRNA in the skin of the mt-
KitV620A Tg-1 and mt- KitV620A Tg-4 mice was examined at 4
weeks after birth. Reverse transcription-PCR analysis was
performed using total RNAs extracted from the shaved skin
and liver. Transgene mRNA expression was detected in
tissues of Tg mice, not in wild-type littermates (Figure 2a). Of
note, the transgene mRNA expression level of mt-KitV620A Tg-4
was obviously higher than that of mt-KitV620A Tg-1. This
difference may well correlate with the fact that the white spot
region was eminently wider in mt-KitV620A Tg-4 than that in
mt-KitV620A Tg-1, given that the dominant-negative effect of
the mt-KitV620A transgene should increase with the increase in
the amount of the mt-KitV620A message. Next, we examined
whether there was a difference in the level of transgene
expression between the white and colored parts of the skin of
mt-KitV620A Tg-1. Slightly more transgene expression was
observed in the colored skin area (Figure 2b). However, the
almost comparable expression in the white skin area
indicates that expression of the transgene in melanocytes of
the pigmented region was overwhelmed by the vast majority
of skin keratinocytes that might also express the MT-I-driven
transgene. Thus, we successfully established a mouse model
of the reported human piebaldism with a Val620Ala mutation
in the KIT gene (Richards et al., 2001).
Stable maintenance of coat color phenotypes of mt-KitV620A Tg
mice
We next determined whether the change in the pattern of the
coat color would take place during the postnatal life of the Tg
mice, because clinical study had reported this Val620Ala
mutation to cause piebaldism with progressive depigmenta-
tion (Richards et al., 2001). However, none of the founders of
mt-KitV620A Tg-1–4 lines exhibited expansion of their white-
spotted areas throughout life (data not shown). Then, all
progenies resulting from mt-KitV620A Tg-1 and -4 founder Tg
animals were crossed with C57BL/6 mice and were also
observed. As early as 4 days after birth, when the first cycles
of hair formation begin, the characteristic coat color patterns
were visible in both lines; but progressive depigmentation
was not seen thereafter throughout their entire life (Figure 3).
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Figure 2. Reverse transcription-PCR assay for the expression of mutant Kit
mRNA of mt-KitV620A Tg-1 and mt-KitV620A Tg-4 mice. Total RNAs extracted
from the mouse skin and liver were used with the primer set MT-F and MT-R
to amplify Tg KIT mRNA. (a) Lanes 1, 2: non-Tg littermate mouse of mt-
KitV620A Tg-1; lanes 3, 4: mt-KitV620A Tg-1; lanes 5, 6: non-Tg littermate
mouse of mt-KitV620A Tg-4; lanes 7, 8: mt-KitV620A Tg-4. All mice were
analyzed at 4 weeks of age. The mutant Kit mRNA expression level,
normalized with respect to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), in mt-KitV620A Tg-4 (lanes 7 and 8) was obviously higher than that
in mt-KitV620A Tg-1 (lanes 3 and 4) in both tissues. (b) RNA was extracted from
a white area (lane 1) and colored area (lane 2) of a 6-week-old mt-KitV620A Tg-1.
In lane 3, skin of a non-Tg littermate was used.
Tg-1
8 days
5 weeks
14 weeks
20 weeks
Tg-4
Figure 3. Stability of coat color phenotypes of mt-KitV620A Tg mice
throughout life. The coat color of mt-KitV620A Tg-1 F1 and mt-Kit
V620A Tg-4 F1
mice at the various ages indicated is shown. For both lines, no noticeable
change in the coat color pattern was observed after birth.
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It is conceivable that depigmentation of the skin is
accompanied by the loss of melanocytes caused by the
reduced self-renewal of melanocyte stem cells in the hair
follicles. To facilitate self-renewal of melanocyte stem cells
and thus increase the chance to visualize depigmentation
induced by the loss of melanocytes, we shaved the hair of mt-
KitV620A Tg-1 and -4 mice (Figure 1b). By this stimulation and
after the entry into a new hair cycle (Hattori and Ogawa,
1983; Ogawa and Hattori, 1983), the hair of all of the Tg
mice maintained exactly the same pattern as seen before
shaving (Figure 1b). Even after a second or third shaving of
these mice, we could not see any change in the pigmentation
patterns (data not shown).
Upregulation of transgene expression by Zn intake still
insufficient to induce postnatal induction of depigmentation
No spreading of white spot regions in KitV620A Tg lines even
after several rounds of stimulation of melanocyte self-renewal
might still be attributed to an insufficient amount of
dominant-negative KitV620A messages from the transgene.
So we then took advantage of the fact that Zn ions are able to
upregulate MT-I promoter activity, as was demonstrated in
previous studies (Palmiter et al., 1993; Bottinger et al., 1997;
Kindy et al., 2000). Induction of the transgene was attained
by the addition of ZnSO4 to the drinking water (25 mM) for 2
weeks. Nine-week-old mt-KitV620A Tg-1 and -4 mice with
littermates were thus administered Zn. After 2 weeks, a
significant increase in transgene expression was observed in
the skin and liver (Figure 4a). In either Tg-1 or -4 Zn-treated
mice, however, there was no expansion of the white spot
regions thereafter (Figure 4b). In addition, we explored the
effect of Zn-induced upregulation of the transgene continu-
ously from newborn to young adult of mt-KitV620A Tg-1 and -4
mice; and in both cases, no hair color pattern change was
observed, regardless of the shaving of the hair (data not
shown). Any increase in transgene expression attained by the
zinc administration did not result in extension of the white
hair regions in KitV620A Tg mice after birth.
To increase the total expression level of the transgene two-
fold, we produced homozygous mt-KitV620A Tg-1 mice. As
expected, these mice had a greatly increased white spot
region (Figure 4c) from neonatal stages; nevertheless, these
homozygous mice did not show any depigmentation in
postnatal life.
Pigmentation pattern of SLF and mt-KitV620A double Tg mice
with pigmented interfollicular skin
Unlike human ones, skin melanocytes in mice survive only in
the hair follicles after birth (Hirobe, 1984); and, therefore, we
may not simply compare the size of the pigmented area in
these two species. To convert the mouse skin so as to permit
melanocyte survival in the interfollicular skin as occurs in
human skin, we previously established Tg mice expressing
SLF, the ligand for KIT, in skin keratinocytes by using the
cytokeratin 14 promoter sequence (SLFTg, Kunisada et al.,
1998). These Tg mice were covered with pigmented
keratinocytes, and melanocytes were maintained in the
epidermis of the interfollicular skin throughout life. Our
double Tg mice, SLFTg/þ /mt-KitV620A Tg-1/þ and SLFTg/þ /
mt-KitV620A Tg-4/þ , had a characteristic hair pigmentation
pattern comparable to that of each KitV620A Tg line, with the
pigmented interfollicular skin strictly restricted to the region
covered with pigmented hair (Figure 5a). We observed a
significant increase in the size of the pigmented area (Figure
5b), as had been observed in double Tg mice of SLFTg and
W57/W57, W/W57, or bt/bt mutants, which might have
occurred during embryogenesis (Kunisada et al., 1998). Also
in this case, even in human-like skin with interfollicular
melanocytes in these SLF and mt-KitV620A double Tg mice, we
could not detect postnatal changes in pigmentation patterns
in either the interfollicular skin or hair, even after shaving of
the pigmented hair or Zn administration (data not shown).
Requirement of KIT signaling to maintain melanocyte stem cells
in pigmented skin areas
In previous sections, all attempts to increase dominant-
negative KitV620A expression in Tg mice to recapitulate the
progressive depigmentation observed in the patients with this
mutation resulted in rather stable maintenance of the pigment
pattern formed during development, even in the mice that
had human-like interfollicular skin melanocytes. We there-
fore speculated that these Tg mice somehow lost their
requirement for KIT signals for the survival of melanocyte
lineage cells. To test this possibility, we administered anti-c-
kit monoclonal antibody (ACK2) to neonatal KitV620A Tg mice
to completely block the KIT signal (Nishikawa et al., 1991).
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Figure 4. Upregulation of transgene expression by Zn intake and production
of homozygous Tg mice. For 2 weeks 9-month-old mt-KitV620A Tg-1 and Tg-4
and their littermates were provided drinking water containing ZnSO4 (25 mM).
(a) RNA samples extracted from the Tg-1 mouse skin and liver before and after
Zn treatment were used to amplify the Kit transgene. Lanes 1, 2: non-Tg
littermate mouse before Zn treatment; lanes 3, 4: non-Tg littermate mouse
after Zn treatment; lanes 5, 6: mt-KitV620A Tg-1 before Zn treatment; lanes 7,
8: mt-KitV620A Tg-1 after Zn treatment. Increased transgene expression in the
skin and liver of mt-KitV620A Tg-1 mice was observed. (b) In Zn-treated
mt-KitV620A Tg-1 and Tg-4 mice, the white spot patterns were the same
before (indicated as Zn) and after (indicated as Znþ ) Zn treatment.
(c) Homozygous mt-KitV620A Tg-1 mice were produced. Genetic crossing of
heterozygous Tg mice produced homozygous (column 1), heterozygous
(columns 2 and 3), and wild-type (column 4) mice.
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After administration of the antibody, the pigmented areas of
mt-KitV620A Tg-1/þ or mt-KitV620A Tg-4/þ mice were
promptly lost (Figure 6), indicating that requirement of KIT
signals for the development of melanocytes from their
precursors or stem cells was not canceled in these Tg mice.
Influence of the mt-KitV620A transgene on mast cell numbers –
implication that the phenotype of Tg mice was a direct effect of
the transgene
The hematopoietic system in mice with a mutation at the KITW
locus is affected in several ways. Effects are seen on the stem
cell compartment, the erythroid cell lineage, and mast cells
(Geissler et al., 1981; Lyon and Glenister, 1982). It was
reported that ectopic expression of a KITW42 minigene in Tg
mice affects mast cell development (Ray et al., 1991). To
evaluate whether transgene expression affected mast cells in
mt-KitV620A Tg, we determined the number of mast cells in skin
sections prepared from these mice. Skin specimens of mt-
KitV620A Tg-1 and mt-KitV620A Tg-4 mice contained 38%
(20.0þ 2.6/cm) and 69% (36.4þ 3.1/cm), respectively, of the
number of mast cells found in the non-Tg littermates
(50.8þ 17.8/cm). Thus, we can conclude that the mt-KitV620A
Tg transgene also affected mast cell development. Collectively
with the coat color changes, these phenotypic changes indicate
a dominant-negative effect of the transgene on KIT signaling.
DISCUSSION
A human piebaldism due to a Val620Ala mutation in the KIT
gene was recapitulated in mice by introducing the same
mutation in the mouse Kit gene followed by forced
expression in melanocytes. Four independent depigmented
Tg lines also showed the loss of mast cells, indicating that loss
of KIT activities induced by Val620Ala is the cause of this
phenotype.
The variability of the coat color phenotype appears to be
the result of clonal variation of the expression of the
transgene. In all four of the Tg lines, mt-KitV620A Tg-1–4,
both the site of chromosomal insertion and the number of
copies of the transgene, are presumed to be random. But we
did not test to see whether different copy numbers of the
transgene had been inserted, because there is no general
relationship between the copy number and the level of
expression (Hammer et al., 1987). However, it is very well
established that expression of transgenes is influenced by
position effects imposed by cis-acting factors at the integra-
tion sites and by strain-specific trans-acting factors that may
induce epigenetic modification of these loci (Lacy et al.,
1983; Allen et al., 1988, 1990; Kothary et al., 1988; Engler
et al., 1991). Thus, position effects and/or differences in
genetic background (Lamoreux, 1999) may determine
the variations in penetrance and expressivity observed in
mt-KitV620A Tg-1–4 mice.
We then tried to find in these mice the progression of
depigmentation observed specifically in the human Val620A-
la mutation in postnatal life. However, we did not see any
changes in the pigmentation pattern in any of the Tg lines
throughout life, even after forced hair cycle progression by
shaving. Furthermore, neither Zn-mediated augmentation of
the transgene regulated by the metallothionein promoter
sequence nor a doubling of the gene dosage by creating
homozygous Tg mice led to any increase in the depigmented
area after birth in any of the individual mice examined.
We next hypothesized that the difference in phenotypes of
Val620Ala mutations in mice and human might be attributed
SLFTg/+; Tg-1/+
SLFTg/+; Tg-1/+
10 days 4 weeks
5 weeks
SLFTg/+; Tg-4/+a
b
Figure 5. Pigmentation pattern of SLF and mt-KitV620A double Tg mice.
(a) Our double Tg mice, SLFTg/þ /mt-KitV620A Tg-1/þ and SLFTg/þ /mt-KitV620A
Tg-4/þ , had a characteristic hair pigmentation pattern comparable to that of
each KitV620A Tg line, with pigmented interfollicular skin strictly restricted to
the region covered with pigmented hair. Part of the coat hair was shaved to
visualize the interfollicular area of melanization, as shown in the lower
panels. (b) In some SLFTg/þ /mt-KitV620A Tg-1/þ mice, the formation of an
apparently wider pigmented area was observed (compare with SLFTg/þ /mt-
KitV620A Tg-1/þ in (a)), although the coat color pattern after birth did not
change as indicated in the lower panel. Part of the coat hair was shaved in the
right panel.
Non Tg-1/Tg
Before ACK2 After ACK2
Non Tg-1 Tg-1
a b c
Figure 6. Effect of ACK2 on the coat color of mt-KitV620A Tg mice. KitV620A
Tg mice and non-Tg littermates were subcutaneously injected with 0.5 mg
ACK2 (anti-Kit) on days 3, 5, 7, 9 after birth. (a) A 3-day-old non-Tg (upper
mouse) and an mt-KitV620A Tg-1 (lower mouse) before ACK2 administration.
(b) A non-Tg without injection (upper) and a non-Tg with ACK2 injection
(lower) on day 13 after birth. (c) A mt-KitV620A Tg-1 without injection (upper)
and a mt-KitV620A Tg-1 with ACK2-injection (lower) on day 13 after birth. As
in the case of the non-Tg mice, the pigmented areas of mt-KitV620A Tg-1 mice
showed a prompt loss of their pigmented areas by day 10 after the first
injection.
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to the difference in the distribution of the melanocytes in the
skin in these two species, as there are fewer interfollicular
melanocytes in the adult mouse skin than in human skin.
Therefore, we crossed mt-KitV620A Tg mice with Tg mice
expressing SLF in which pigmented keratinocytes and
melanocytes were maintained in the epidermis of the
interfollicular skin. Also in these double Tg animals, we
never observed any increase in the white spotted region after
birth. Under the condition in which melanocytes in the
interfollicular skin were stably maintained as in human skin,
the Val620Ala mutation in the mouse Kit gene did not induce
progression of depigmentation as observed specifically for the
same mutation in humans.
Our study with Tg mice provides evidence that the KIT
Val620Ala mutation itself is not sufficient to give the very
unusual phenotype of progressive loss of pigmented areas.
The most obvious alternative explanation for the piebald
mother and daughter, as pointed out by the authors of the
original report, is that a mutation in a second, unknown gene
might have led to the increased susceptibility for progressive
pigment loss. This presumption can be supported by the
finding that some other family members showed minor
postnatal pigmentary loss without having the KIT mutation
(Richards et al., 2001). Thus, this particular KIT mutation
would then be no different from others discovered nearby in
the coding sequence. As other possible alternative explana-
tions for our negative observations, we may speculate that
there is some fundamental difference between human and
mouse melanocyte maintenance, that the use of the MT-I
promoter instead of the KIT promoter contributed to our
results, or that the lifespan of mice is just too short to allow
the expansion of the depigmented areas observed in the
human kindred over many years. But in order to distinguish
among these different explanations and specify the mechan-
ism for appearance of the human novel phenotype, more
additional analysis concerning the reported family as well as
further clarification of many unknown aspects of the
generation, differentiation, maintenance, and survival of
melanocytes in both human and mice is necessary.
In mt-KitV620A Tg-1 and mt-KitV620A Tg-4 mice, the number
of mast cells was 38 and 69%, respectively, of that for each
control mice. Although this result is in contrast to the
pigmentary aspects of the mt-KitV620A Tg-1 and mt-KitV620A
Tg-4 mice, it agrees with a previous report on Kit Tg mice
(Ray et al., 1991). As the previous report has also described,
these results may indicate different levels of transgene
expression in mast cells and melanoblasts of the two lines;
and they may reflect the different microenvironments of
connective tissue mast cells and melanocytes in the skin. For
example, whereas mast cells are found only in the dermis,
melanocytes are found in the dermis and in the epidermis
(hair follicles; Nakayama et al., 1988).
There exist mainly two phases requiring KIT signals in
melanocyte development: firstly in the early development of
melanocyte stem cells soon after their specification from
neural crest cells in the embryonic trunk up to their entry into
developing hair follicles in the skin, and secondly in the
cyclic activation of melanocyte stem cells in the hair follicles
throughout postnatal life. In the first phase, the pattern of the
final melanocyte distribution in the skin are sensitively
affected by KIT activities and the characteristic white
spottings are indicative of individual Kit mutations that result
in different amounts of KIT tyrosine kinase activity (Yoshida
et al., 1993). In other words, the extent of white spotted area
is completely determined in this first developmental stage by
the amount of available KIT activities in melanocyte
precursors. In contrast, after birth the melanocytes are stably
maintained in the pigmented area; and the proportions of
their existing area characteristic to individual spotting
patterns are strictly conserved along with the growth of the
body. In the second phase, melanocytes or their precursors
seem to require the least amount of KIT signaling. In the case
of mt-KitV620A Tg-4/þ mice, only several bands of pigmented
hair were formed in the trunk region, indicating that almost
all of the KIT activities were blocked by the expression of the
Val620Ala mutant Kit gene in the embryonic skin. In this
extreme case and even after shaving the hair of the Tg mice to
stimulate KIT-dependent growth of melanocyte stem cells in
the hair follicles, no indication of progressive loss of
pigmented area including hair graying was observed. There-
fore, unexpectedly we demonstrated an extremely stable
maintenance of the melanocyte stem cell system under
stringent conditions for KIT signaling. However, as previously
indicated (Nishikawa et al., 1991; Okura et al., 1995;
Kunisada et al., 1998; Botchkareva et al., 2001), complete
blockade of KIT signals by the administration of anti-KIT
antibody faded the once established pigmented areas in these
Tg mice, indicating that at least a small level of KIT signaling
was required for their survival.
MATERIALS AND METHODS
Transgene construct
The parent expression vector 2999 (Palmiter et al., 1993) was
obtained from Dr Richard Palmiter (University of Washington,
Seattle). This vector has 814 bp of the mouse MT-I promoter fused
via an NruI linker to 650 bp of the human growth hormone 30
untranslated region and polyadenylation signal, and has 10 kb of MT
locus containing a 50 DNase hypersensitive site and 7 kb of it
containing a 30 DNase hypersensitive site. Unique SalI (or ClaI and
SstI) sites flanking the mouse sequences were used to remove the
Bluescript-based vector sequences. Because we had difficulty in
cloning a cDNA directly into the NruI-digested blunt ends of this
large plasmid, we used the following strategy: Vector 2999 was
digested with NotI to isolate a 1.4-kb fragment containing 814 bp of
the MT-I promoter, the NruI cloning site, and 650 bp of the human
growth hormone 30 untranslated region. This fragment was then
inserted into the NotI site of pBluescript II KS(þ ). After the mouse
Val620Ala Kit cDNA fragment, described later, had been inserted
into the NruI site of this plasmid, the plasmid was then digested with
NotI. The isolated NotI fragment was ligated with the NotI-digested
20-kb fragment of 2,999 from which the MT-I promoter, the NruI
cloning site, and the human growth hormone 30 untranslated region
had been removed, thus creating 2,999MT mVal620Ala Kit.
The mouse Val620Ala Kit cDNA fragment was prepared as
follows: pBluescript II KS(þ ) lacking an ApaI site (pBSdApaI) was
prepared by digestion of pBluescript II KS(þ ) with ApaI and
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was blunt ended and self-ligated. The mouse Kit cDNA cloned into
the EcoRI and HindIII site of pUC19 was digested with EcoRI and
HindIII, and the resulting 2.9-kb Kit cDNA fragment was then
inserted into the EcoRI and HindIII site of pBSdApaI and designated
as pBSdApaI/mKit. A 196-bp DNA fragment containing a Val620Ala
(corresponding to Val619Ala, 1,856 T-C in the mouse Kit gene)
mutation was synthesized by PCR using pBSdApaI/mKit as a
template with the following primer set: KitVal620Ala-Sense
(50-CTGCATATGGCTTGATTAAGTCGGATGCTGCCATGACAGCTG
CCG-30; containing an NdeI site and 1,856 T-C mutation), and
KitVal620Ala-Antisense (50-TATTCTGTAATGACCAGGGTGGGCCC
TCC-30; containing an ApaI site). Presence of the mutation was
confirmed by direct sequencing after cloning the fragment by use of
the pGEM-T Easy Vector System (Promega, Madison, WI). Then, the
168-bp fragment was cut from the vector with NdeI and ApaI, and
ligated into the pBSdApaI/mKit plasmid digested with NdeI and ApaI
to obtain pBSdApaI/mVal620Ala Kit. This plasmid was digested with
PstI and blunt ended to prepare the mouse Val620Ala Kit cDNA
fragment.
Generation and identification of Tg mice
2,999MT-mVal620Ala Kit was digested with ClaI and SstII (Figure 7),
and the transgene DNA fragment separated from the vector sequence
was isolated by using agarose gel electrophoresis and cleaned with a
Geneclean Kit (Bio 101, Carlsbad, CA). The purified DNA fragment
was microinjected into pronuclei of day 0.5 Slc/BDF1. Injected
embryos were implanted into the oviducts of day –0.5 pseudopreg-
nant female Slc/ICR mice. Tg mice were identified by PCR by using
the following primer set: MT-F (50-GAGTGCAGTGGCACAA
TCTTGGCTC-30) and MT-R (50-GCATGAGAGGACAGTGCCAAGC
AAG-30), both corresponding to the human growth hormone 30
untranslated region. The Tg mice were maintained within C57BL/6
mice afterwards. The medical ethical committee of the Gifu
University approved all described studies.
RNA extraction and reverse transcription-PCR analysis
Total RNA was extracted from the mouse skin by using ISOGEN
(Nippon Gene, Tokyo, Japan) as described by the manufacturer. The
extracted total RNA (5 mg) was reverse transcribed in a 20-ml reaction
mixture by using a SuperScript First Strand Synthesis System
(Invitrogen, Carlsbad, CA). One microliter of the resulting first-
strand cDNA mixture was used for PCR with Taq polymerase
(Takara, Tokyo, Japan), which amplification was performed in a
50-ml mixture. Ten microliters of each PCR product was subjected to
electrophoresis on a 2.0% agarose gel and visualized with ethidium
bromide. Primers used for PCR were as follow: MT-F, MT-R,
glyceraldehyde-3-phosphate dehydrogenase-F (50-CTTCACCAC
CATGGAGAAGGC-30), and glyceraldehyde-3-phosphate dehydro-
genase-R (50-GGCATGGACTGTGGTCATGAG-30).
Staining and counting of mast cell
Mice at 6–7 weeks of age were killed after anesthesia. Pieces of the
dorsal skin were removed with a 6 mm diameter punch and were
embedded in paraffin. Sections (4-mm thickness) were stained with
alcian blue according to standard procedures (Kunisada et al., 1998).
Mast cells lying between the epithelium and panniculus carnosus in
five specimens for each Tg mouse were counted under a
microscope, and the numbers were converted into the number per
cm of skin specimen.
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